Company / EPS (Basic)
Orchestra BioMed Holdings, Inc. EPS (Basic) History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$1.66
FY2025
5-year range
-$2.24 / -$1.48
FY2023-FY2025
Trend
-12.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-2.24 to $-1.66 over the past 2 years.
Based on SEC 10-K filings.
-1.66 in FY2025.
Improved from $-2.24 to $-1.66 over the past 2 years.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (basic) decreased 12.2% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.98 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.66 | -12.2% |
| FY2024 | -$1.48 | +33.9% |
| FY2023 | -$2.24 | - |
As of FY2025 · SEC 10-K Annual Filings · Last checked Jun 28, 2026